James B Rowe - Publications

Affiliations: 
University of Cambridge, Cambridge, England, United Kingdom 
Area:
Cognition, Prefrontal, Parkinson's

199 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Tomassini A, Cope TE, Zhang J, Rowe JB. Parkinson's disease impairs cortical sensori-motor decision-making cascades. Brain Communications. 6: fcae065. PMID 38505233 DOI: 10.1093/braincomms/fcae065  0.541
2022 Tomassini A, Hezemans FH, Ye R, Tsvetanov KA, Wolpe N, Rowe JB. Prefrontal cortical connectivity mediates locus coeruleus noradrenergic regulation of inhibitory control in older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 35277392 DOI: 10.1523/JNEUROSCI.1361-21.2022  0.528
2020 Low A, Mak E, Malpetti M, Passamonti L, Nicastro N, Stefaniak JD, Savulich G, Chouliaras L, Su L, Rowe JB, Markus HS, O'Brien JT. In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32917821 DOI: 10.1136/Jnnp-2020-323894  0.343
2020 Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Meissner WG, ... ... Rowe JB, et al. Clinical Conditions "Suggestive of Progressive Supranuclear Palsy"-Diagnostic Performance. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32914550 DOI: 10.1002/Mds.28263  0.319
2020 Tavares TP, Mitchell DGV, Coleman KK, Coleman BL, Shoesmith CL, Butler CR, Santana I, Danek A, Gerhard A, de Mendonca A, Borroni B, Tartaglia MC, Graff C, Galimberti D, Tagliavini F, ... ... Rowe JB, et al. Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32769115 DOI: 10.1136/Jnnp-2020-322987  0.31
2020 Nicastro N, Malpetti M, Mak E, Williams GB, Bevan-Jones WR, Carter SF, Passamonti L, Fryer TD, Hong YT, Aigbirhio FI, Rowe JB, O'Brien JT. Gray matter changes related to microglial activation in Alzheimer's disease. Neurobiology of Aging. 94: 236-242. PMID 32663716 DOI: 10.1016/J.Neurobiolaging.2020.06.010  0.388
2020 Nicastro N, Malpetti M, Cope TE, Bevan-Jones WR, Mak E, Passamonti L, Rowe JB, O'Brien JT. Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia. Journal of Alzheimer's Disease : Jad. PMID 32444550 DOI: 10.3233/Jad-200246  0.379
2020 Murley AG, Coyle-Gilchrist I, Rouse MA, Jones PS, Li W, Wiggins J, Lansdall C, Rodríguez PV, Wilcox A, Tsvetanov KA, Patterson K, Lambon Ralph MA, Rowe JB. Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes. Brain : a Journal of Neurology. 143: 1555-1571. PMID 32438414 DOI: 10.1093/Brain/Awaa097  0.336
2020 Malpetti M, Kievit RA, Passamonti L, Jones PS, Tsvetanov KA, Rittman T, Mak E, Nicastro N, Bevan-Jones WR, Su L, Hong YT, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease. Brain : a Journal of Neurology. PMID 32380523 DOI: 10.1093/Brain/Awaa088  0.398
2020 Kocagoncu E, Quinn A, Firouzian A, Cooper E, Greve A, Gunn R, Green G, Woolrich MW, Henson RN, Lovestone S, Rowe JB. Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics. Neurobiology of Aging. PMID 32280029 DOI: 10.1016/J.Neurobiolaging.2020.03.009  0.356
2020 Murley AG, Jones PS, Coyle Gilchrist I, Bowns L, Wiggins J, Tsvetanov KA, Rowe JB. Metabolomic changes associated with frontotemporal lobar degeneration syndromes. Journal of Neurology. PMID 32277260 DOI: 10.1007/S00415-020-09824-1  0.311
2020 Liu KY, Kievit RA, Tsvetanov KA, Betts MJ, Düzel E, Rowe JB, Howard R, Hämmerer D. Noradrenergic-dependent functions are associated with age-related locus coeruleus signal intensity differences. Nature Communications. 11: 1712. PMID 32249849 DOI: 10.1038/S41467-020-15410-W  0.302
2020 Wolpe N, Ingram JN, Tsvetanov KA, Henson RN, Wolpert DM, Rowe JB. Age-related reduction in motor adaptation: brain structural correlates and the role of explicit memory. Neurobiology of Aging. PMID 32184030 DOI: 10.1016/J.Neurobiolaging.2020.02.016  0.301
2020 Bevan-Jones WR, Cope TE, Jones PS, Kaalund SS, Passamonti L, Allinson K, Green O, Hong YT, Fryer TD, Arnold R, Coles JP, Aigbirhio FI, Larner AJ, Patterson K, O'Brien JT, ... Rowe JB, et al. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum. Brain : a Journal of Neurology. PMID 32179883 DOI: 10.1093/Brain/Awaa033  0.35
2020 Wolpe N, Hezemans FH, Rowe JB. Alien limb syndrome: A Bayesian account of unwanted actions. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 127: 29-41. PMID 32155475 DOI: 10.1016/J.Cortex.2020.02.002  0.329
2020 Jensen MP, Spasic-Boskovic O, Rowe JB, Galton C, Allinson KSJ. Clinicopathological co-occurrence of Fahr's disease and dementia with Lewy bodies. Clinical Neuropathology. PMID 32145757 DOI: 10.5414/Np301267  0.349
2020 Nicastro N, Mak E, Williams GB, Surendranathan A, Bevan-Jones WR, Passamonti L, Vàzquez Rodrìguez P, Su L, Arnold R, Fryer TD, Hong YT, Aigbirhio FI, Rowe JB, O'Brien JT. Correlation of microglial activation with white matter changes in dementia with Lewy bodies. Neuroimage. Clinical. 25: 102200. PMID 32032816 DOI: 10.1016/J.Nicl.2020.102200  0.369
2020 Moore K, Convery R, Bocchetta M, Neason M, Cash DM, Greaves C, Russell LL, Clarke MTM, Peakman G, van Swieten J, Jiskoot L, Moreno F, Barandiaran M, Sanchez-Valle R, Borroni B, ... ... Rowe JB, et al. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort. Applied Neuropsychology. Adult. 1-8. PMID 32024404 DOI: 10.1080/23279095.2020.1716357  0.328
2020 Kaalund SS, Passamonti L, Allinson KSJ, Murley AG, Robbins TW, Spillantini MG, Rowe JB. Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity. Acta Neuropathologica Communications. 8: 11. PMID 32019605 DOI: 10.1186/S40478-020-0886-0  0.345
2020 Lewis-Smith DJ, Wolpe N, Ghosh BCP, Rowe JB. Alien limb in the corticobasal syndrome: phenomenological characteristics and relationship to apraxia. Journal of Neurology. PMID 31919566 DOI: 10.1007/S00415-019-09672-8  0.316
2020 Adams NE, Hughes LE, Phillips HN, Shaw AD, Murley AG, Nesbitt D, Cope TE, Bevan-Jones WR, Passamonti L, Rowe JB. GABA-ergic dynamics in human frontotemporal networks confirmed by pharmaco-magnetoencephalography. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31915255 DOI: 10.1523/Jneurosci.1689-19.2019  0.316
2019 Sudre CH, Bocchetta M, Heller C, Convery R, Neason M, Moore KM, Cash DM, Thomas DL, Woollacott IOC, Foiani M, Heslegrave A, Shafei R, Greaves C, van Swieten J, Moreno F, ... ... Rowe JB, et al. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study. Neuroimage. Clinical. 24: 102077. PMID 31835286 DOI: 10.1016/J.Nicl.2019.102077  0.349
2019 Moore KM, Nicholas J, Grossman M, McMillan CT, Irwin DJ, Massimo L, Van Deerlin VM, Warren JD, Fox NC, Rossor MN, Mead S, Bocchetta M, Boeve BF, Knopman DS, Graff-Radford NR, ... ... Rowe JB, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. The Lancet. Neurology. PMID 31810826 DOI: 10.1016/S1474-4422(19)30394-1  0.311
2019 Rowe JB. Parkinsonism in frontotemporal dementias. International Review of Neurobiology. 149: 249-275. PMID 31779815 DOI: 10.1016/Bs.Irn.2019.10.012  0.384
2019 Low A, Mak E, Malpetti M, Chouliaras L, Nicastro N, Su L, Holland N, Rittman T, Rodríguez PV, Passamonti L, Bevan-Jones WR, Jones PS, Rowe JB, O'Brien JT. Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 690-699. PMID 31667328 DOI: 10.1016/J.Dadm.2019.08.001  0.372
2019 Shafto MA, Henson RN, Matthews FE, Taylor JR, Emery T, Erzinclioglu S, Hanley C, Rowe JB, Cusack R, Calder AJ, Marslen-Wilson WD, Duncan J, Dalgleish T, Brayne C, Cam-Can, et al. Cognitive Diversity in a Healthy Aging Cohort: Cross-Domain Cognition in the Cam-CAN Project. Journal of Aging and Health. 898264319878095. PMID 31592706 DOI: 10.1177/0898264319878095  0.303
2019 Nicastro N, Surendranathan A, Mak E, Rowe JB, O'Brien JT. C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia. Annals of Clinical and Translational Neurology. PMID 31507085 DOI: 10.1002/Acn3.50877  0.374
2019 Hughes LE, Henson RN, Pereda E, Bruña R, López-Sanz D, Quinn AJ, Woolrich MW, Nobre AC, Rowe JB, Maestú F. Biomagnetic biomarkers for dementia: A pilot multicentre study with a recommended methodological framework for magnetoencephalography. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 450-462. PMID 31431918 DOI: 10.1016/J.Dadm.2019.04.009  0.303
2019 Düzel E, Acosta-Cabronero J, Berron D, Biessels GJ, Björkman-Burtscher I, Bottlaender M, Bowtell R, Buchem MV, Cardenas-Blanco A, Boumezbeur F, Chan D, Clare S, Costagli M, de Rochefort L, Fillmer A, ... ... Rowe JB, et al. European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND). Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 538-549. PMID 31388558 DOI: 10.1016/J.Dadm.2019.04.010  0.313
2019 Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, ... ... Rowe JB, et al. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain : a Journal of Neurology. PMID 31327002 DOI: 10.1093/Brain/Awz193  0.386
2019 Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, Mak E, Su L, O'Brien JT, Rowe JB. Neuroinflammation and functional connectivity in Alzheimer's disease: interactive influences on cognitive performance. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31320450 DOI: 10.1523/Jneurosci.2574-18.2019  0.408
2019 Mauricio R, Benn C, Davis J, Dawson G, Dawson LA, Evans A, Fox N, Gallacher J, Hutton M, Isaac J, Jones DNC, Jones L, Lalli G, Libri V, Lovestone S, ... ... Rowe J, et al. Tackling gaps in developing life-changing treatments for dementia. Alzheimer's & Dementia (New York, N. Y.). 5: 241-253. PMID 31297438 DOI: 10.1016/J.Trci.2019.05.001  0.322
2019 Bischof GN, Ewers M, Franzmeier N, Grothe MJ, Hoenig M, Kocagoncu E, Neitzel J, Rowe JB, Strafella A, Drzezga A, van Eimeren T. Connectomics and molecular imaging in neurodegeneration. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31292699 DOI: 10.1007/S00259-019-04394-5  0.312
2019 Shaw AD, Hughes LE, Moran R, Coyle-Gilchrist I, Rittman T, Rowe JB. In Vivo Assay of Cortical Microcircuitry in Frontotemporal Dementia: A Platform for Experimental Medicine Studies. Cerebral Cortex (New York, N.Y. : 1991). PMID 31216360 DOI: 10.1093/Cercor/Bhz024  0.356
2019 Gazzina S, Grassi M, Premi E, Cosseddu M, Alberici A, Archetti S, Gasparotti R, Van Swieten J, Galimberti D, Sanchez-Valle R, Laforce RJ, Moreno F, Synofzik M, Graff C, Masellis M, ... ... Rowe JB, et al. Education modulates brain maintenance in presymptomatic frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31182509 DOI: 10.1136/Jnnp-2019-320439  0.324
2019 Koriath C, Lashley T, Taylor W, Druyeh R, Dimitriadis A, Denning N, Williams J, Warren JD, Fox NC, Schott JM, Rowe JB, Collinge J, Rohrer JD, Mead S. ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 277-280. PMID 30949567 DOI: 10.1016/J.Dadm.2019.01.010  0.319
2019 Koychev I, Lawson J, Chessell T, Mackay C, Gunn R, Sahakian B, Rowe JB, Thomas AJ, Rochester L, Chan D, Tom B, Malhotra P, Ballard C, Chessell I, Ritchie CW, et al. Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease. Bmj Open. 9: e024498. PMID 30904851 DOI: 10.1136/Bmjopen-2018-024498  0.349
2019 Mutsaerts HJMM, Mirza SS, Petr J, Thomas DL, Cash DM, Bocchetta M, de Vita E, Metcalfe AWS, Shirzadi Z, Robertson AD, Tartaglia MC, Mitchell SB, Black SE, Freedman M, Tang-Wai D, ... ... Rowe JB, et al. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study. Brain : a Journal of Neurology. PMID 30847466 DOI: 10.1093/Brain/Awz039  0.324
2019 Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FI, O'Brien JT, Rowe JB. In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier. Annals of Clinical and Translational Neurology. 6: 373-378. PMID 30847369 DOI: 10.1002/Acn3.683  0.327
2019 Rittman T, Borchert R, Jones S, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Graff C, Tagliavini F, Frisoni GB, Laforce R, Finger E, Mendonça A, Sorbi S, ... ... Rowe JB, et al. Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia. Neurobiology of Aging. 77: 169-177. PMID 30831384 DOI: 10.1016/J.Neurobiolaging.2018.12.009  0.363
2019 Premi E, Calhoun VD, Diano M, Gazzina S, Cosseddu M, Alberici A, Archetti S, Paternicò D, Gasparotti R, van Swieten J, Galimberti D, Sanchez-Valle R, Laforce R, Moreno F, Synofzik M, ... ... Rowe J, et al. The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint. Neuroimage. PMID 30716457 DOI: 10.1016/J.Neuroimage.2019.01.080  0.348
2019 Malpetti M, Passamonti L, Kievit RA, Jones PS, Tsvetanov KA, Rittman T, Mak E, Bevan-Jones WR, Holland N, Nicastro N, Rodríguez PV, Aigbirhio FI, O'Brien JT, Rowe JB. Ic-P-088: Microglial Activation And Tau Burden Predict Cognitive Decline In Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4762  0.333
2019 Malpetti M, Kievit RA, Jones PS, Rittman T, Tsvetanov KA, van Swieten JC, Borroni B, Galimberti D, Sanchez-Valle R, Laforce R, Moreno F, Synofzik M, Graff C, Masellis M, Tartaglia C, ... ... Rowe JB, et al. O4-03-06: LONGITUDINAL ASSOCIATION BETWEEN APATHY AND COGNITIVE DECLINE IN PRE- AND POST-SYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA Alzheimer's & Dementia. 15: P1237-P1237. DOI: 10.1016/J.Jalz.2019.06.4757  0.316
2019 Moore KM, Nicholas JM, Convery RS, Greaves CV, Bocchetta M, Neason MR, Cash DM, Gerhard A, Butler CR, Rowe JB, Rohrer JD. Genfi Ignite: A Novel Cognitive Assessment App For Testing Presymptomatic Frontotemporal Dementia Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4329  0.32
2019 Low A, Mak E, Malpetti M, Chouliaras L, Nicastro N, Su L, Holland N, Rittman T, Rodríguez PV, Passamonti L, Bevan-Jones WR, Jones PS, Rowe JB, O'Brien JT. P2-373: Asymmetrical Thalamic Subnuclei In Alzheimer'S Disease Associated With Greater Disease Severity Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2780  0.328
2018 Passamonti L, Lansdall C, Rowe JB. The neuroanatomical and neurochemical basis of apathy and impulsivity in frontotemporal lobar degeneration. Current Opinion in Behavioral Sciences. 22: 14-20. PMID 31032387 DOI: 10.1016/J.Cobeha.2017.12.015  0.345
2018 Cury C, Durrleman S, Cash DM, Lorenzi M, Nicholas JM, Bocchetta M, van Swieten JC, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, et al. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort. Neuroimage. 188: 282-290. PMID 30529631 DOI: 10.1016/J.Neuroimage.2018.11.063  0.384
2018 Meder D, Herz DM, Rowe JB, Lehéricy S, Siebner HR. The role of dopamine in the brain - Lessons learned from Parkinson's disease. Neuroimage. PMID 30465864 DOI: 10.1016/J.Neuroimage.2018.11.021  0.374
2018 Mak E, Bethlehem RAI, Romero-Garcia R, Cervenka S, Rittman T, Gabel S, Surendranathan A, Bevan-Jones RW, Passamonti L, Vázquez Rodríguez P, Su L, Arnold R, Williams GB, Hong YT, Fryer TD, ... ... Rowe JB, et al. In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 678-687. PMID 30426064 DOI: 10.1016/J.Dadm.2018.08.005  0.334
2018 Surendranathan A, Su L, Mak E, Passamonti L, Hong YT, Arnold R, Vázquez Rodríguez P, Bevan-Jones WR, Brain SAE, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT. Early microglial activation and peripheral inflammation in dementia with Lewy bodies. Brain : a Journal of Neurology. PMID 30403785 DOI: 10.1093/Brain/Awy265  0.363
2018 Wolpe N, Zhang J, Nombela C, Ingram JN, Wolpert DM, Rowe JB. Sensory attenuation in Parkinson's disease is related to disease severity and dopamine dose. Scientific Reports. 8: 15643. PMID 30353104 DOI: 10.1038/S41598-018-33678-3  0.308
2018 Bevan-Jones RW, Cope TE, Jones SP, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FA, Patterson K, O'Brien JT, Rowe JB. [F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion. Annals of Clinical and Translational Neurology. 5: 1292-1296. PMID 30349864 DOI: 10.1002/Acn3.631  0.312
2018 Su L, Huang Y, Wang Y, Rowe J, O'Brien J. Predict Disease Progression With Reaction Rate Equation Modeling of Multimodal MRI and PET. Frontiers in Aging Neuroscience. 10: 306. PMID 30349473 DOI: 10.3389/Fnagi.2018.00306  0.377
2018 Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, ... Rowe JB, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nature Communications. 9: 4273. PMID 30323170 DOI: 10.1038/S41467-018-05892-0  0.359
2018 Skandali N, Rowe JB, Voon V, Deakin JB, Cardinal RN, Cormack F, Passamonti L, Bevan-Jones WR, Regenthal R, Chamberlain SR, Robbins TW, Sahakian BJ. Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30305705 DOI: 10.1038/S41386-018-0229-Z  0.322
2018 Koriath C, Kenny J, Adamson G, Druyeh R, Taylor W, Beck J, Quinn L, Mok TH, Dimitriadis A, Norsworthy P, Bass N, Carter J, Walker Z, Kipps C, Coulthard E, ... ... Rowe JB, et al. Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series. Molecular Psychiatry. PMID 30279455 DOI: 10.1038/S41380-018-0224-0  0.316
2018 Koychev I, Galna B, Zetterberg H, Lawson J, Zamboni G, Ridha BH, Rowe JB, Thomas A, Howard R, Malhotra P, Ritchie C, Lovestone S, Rochester L. Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 30198873 DOI: 10.3233/Jad-180622  0.333
2018 Sami S, Williams N, Hughes LE, Cope TE, Rittman T, Coyle-Gilchrist ITS, Henson RN, Rowe JB. Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype. Brain : a Journal of Neurology. 141: 2500-2510. PMID 30060017 DOI: 10.1093/Brain/Awy180  0.398
2018 Tsvetanov KA, Ye Z, Hughes L, Samu D, Treder MS, Wolpe N, Tyler LK, Rowe JB. Activity and connectivity differences underlying inhibitory control across the adult lifespan. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30049889 DOI: 10.1523/Jneurosci.2919-17.2018  0.349
2018 Sellami L, Bocchetta M, Masellis M, Cash DM, Dick KM, van Swieten J, Borroni B, Galimberti D, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni G, Finger E, de Mendonça A, et al. Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort. Journal of Alzheimer's Disease : Jad. PMID 30010122 DOI: 10.3233/Jad-180053  0.31
2018 Hughes LE, Rittman T, Robbins TW, Rowe JB. Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia. Brain : a Journal of Neurology. PMID 29992242 DOI: 10.1093/Brain/Awy176  0.36
2018 Fumagalli GG, Basilico P, Arighi A, Bocchetta M, Dick KM, Cash DM, Harding S, Mercurio M, Fenoglio C, Pietroboni AM, Ghezzi L, van Swieten J, Borroni B, de Mendonça A, Masellis M, ... ... Rowe JB, et al. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales. Alzheimer's Research & Therapy. 10: 46. PMID 29793546 DOI: 10.1186/S13195-018-0376-9  0.326
2018 Passamonti L, Rodríguez PV, Hong YT, Allinson KSJ, Bevan-Jones WR, Williamson D, Jones PS, Arnold R, Borchert RJ, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, ... Rowe JB, et al. [C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy. Neurology. PMID 29703774 DOI: 10.1212/Wnl.0000000000005610  0.325
2018 Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study. Journal of Neurology. PMID 29696499 DOI: 10.1007/S00415-018-8873-0  0.37
2018 Mc Ardle R, Morris R, Hickey A, Del Din S, Koychev I, Gunn RN, Lawson J, Zamboni G, Ridha B, Sahakian BJ, Rowe JB, Thomas A, Zetterberg H, MacKay C, Lovestone S, et al. Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 29614664 DOI: 10.3233/Jad-171116  0.348
2018 Lansdall CJ, Coyle-Gilchrist ITS, Jones PS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Dick KM, Robbins TW, Rowe JB. White matter change with apathy and impulsivity in frontotemporal lobar degeneration syndromes. Neurology. PMID 29453244 DOI: 10.1212/Wnl.0000000000005175  0.321
2018 Murley AG, Rowe JB. Neurotransmitter deficits from frontotemporal lobar degeneration. Brain : a Journal of Neurology. PMID 29373632 DOI: 10.1093/Brain/Awx327  0.32
2017 Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K, Passamonti L, Vazquez Rodriguez P, Bevan-Jones WR, O'Brien JT, Rowe JB. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy. Brain : a Journal of Neurology. PMID 29293892 DOI: 10.1093/Brain/Awx347  0.379
2017 Cope TE, Sohoglu E, Sedley W, Patterson K, Jones PS, Wiggins J, Dawson C, Grube M, Carlyon RP, Griffiths TD, Davis MH, Rowe JB. Evidence for causal top-down frontal contributions to predictive processes in speech perception. Nature Communications. 8: 2154. PMID 29255275 DOI: 10.1038/S41467-017-01958-7  0.311
2017 Cash DM, Bocchetta M, Thomas DL, Dick KM, van Swieten JC, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R, Finger E, et al. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study. Neurobiology of Aging. 62: 191-196. PMID 29172163 DOI: 10.1016/J.Neurobiolaging.2017.10.008  0.348
2017 Su L, Hayes L, Soteriades S, Williams G, Brain SAE, Firbank MJ, Longoni G, Arnold RJ, Rowe JB, O'Brien JT. Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 29171994 DOI: 10.3233/Jad-170344  0.338
2017 Underwood BR, Green-Thompson ZW, Pugh PJ, Lazic SE, Mason SL, Griffin J, Jones PS, Rowe JB, Rubinsztein DC, Barker RA. An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease. Journal of Neurology. PMID 29075837 DOI: 10.1007/S00415-017-8647-0  0.322
2017 Brown JM, Lansdall CJ, Wiggins J, Dawson KE, Hunter K, Rowe JB, Parker RA. The Test Your Memory for Mild Cognitive Impairment (TYM-MCI). Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28912299 DOI: 10.1136/Jnnp-2016-315327  0.327
2017 Koychev I, Gunn RN, Firouzian A, Lawson J, Zamboni G, Ridha B, Sahakian BJ, Rowe JB, Thomas A, Rochester L, Ffytche D, Howard R, Zetterberg H, MacKay C, Lovestone S, et al. PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers. Journal of Alzheimer's Disease : Jad. PMID 28800330 DOI: 10.3233/Jad-170129  0.331
2017 Sudre CH, Bocchetta M, Cash D, Thomas DL, Woollacott I, Dick KM, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni G, et al. White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort. Neuroimage. Clinical. 15: 171-180. PMID 28529873 DOI: 10.1016/J.Nicl.2017.04.015  0.309
2017 Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, ... ... Rowe JB, et al. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28500752 DOI: 10.1002/Mds.27034  0.305
2017 Lansdall CJ, Coyle-Gilchrist ITS, Jones PS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Dick KM, Robbins TW, Rowe JB. Apathy and impulsivity in frontotemporal lobar degeneration syndromes. Brain : a Journal of Neurology. PMID 28486594 DOI: 10.1093/Brain/Awx101  0.388
2017 Premi E, Grassi M, van Swieten J, Galimberti D, Graff C, Masellis M, Tartaglia C, Tagliavini F, Rowe JB, Laforce R, Finger E, Frisoni GB, de Mendonça A, Sorbi S, Gazzina S, et al. Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study. Brain : a Journal of Neurology. PMID 28460069 DOI: 10.1093/Brain/Awx103  0.364
2017 Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Mollenhauer B, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease. Neurobiology of Aging. 55: 78-90. PMID 28431288 DOI: 10.1016/J.Neurobiolaging.2017.03.012  0.319
2017 Kehagia AA, Ye R, Joyce DW, Doyle OM, Rowe JB, Robbins TW. Parsing the Roles of the Frontal Lobes and BG in Task Control Using Multivoxel Pattern Analysis. Journal of Cognitive Neuroscience. 1-12. PMID 28387585 DOI: 10.1162/Jocn_A_01130  0.361
2017 Lehericy S, Vaillancourt DE, Seppi K, Monchi O, Rektorova I, Antonini A, McKeown MJ, Masellis M, Berg D, Rowe JB, Lewis SJ, Williams-Gray CH, Tessitore A, Siebner HR. The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28370449 DOI: 10.1002/Mds.26968  0.321
2017 Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O'Brien JT. in vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings. Ageing Research Reviews. PMID 28315409 DOI: 10.1016/J.Arr.2017.03.002  0.363
2017 Kaser M, Deakin JB, Michael A, Zapata C, Bansal R, Ryan D, Cormack F, Rowe JB, Sahakian BJ. Modafinil Improves Episodic Memory and Working Memory Cognition in Patients With Remitted Depression: A Double-Blind, Randomized, Placebo-Controlled Study. Biological Psychiatry : Cognitive Neuroscience and Neuroimaging. 2: 115-122. PMID 28299368 DOI: 10.1016/J.Bpsc.2016.11.009  0.3
2017 Passamonti L, Vázquez Rodríguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, ... ... Rowe JB, et al. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy. Brain : a Journal of Neurology. PMID 28122879 DOI: 10.1093/Brain/Aww340  0.337
2017 Mak E, Gabel S, Su L, Williams GB, Arnold R, Passamonti L, Vazquez Rodríguez P, Surendranathan A, Bevan-Jones WR, Rowe JB, O'Brien JT. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies. International Psychogeriatrics. 1-11. PMID 28088928 DOI: 10.1017/S1041610216002143  0.379
2017 Bevan-Jones WR, Surendranathan A, Passamonti L, Vázquez Rodríguez P, Arnold R, Mak E, Su L, Coles JP, Fryer TD, Hong YT, Williams G, Aigbirhio F, Rowe JB, O'Brien JT. Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses. Bmj Open. 7: e013187. PMID 28064175 DOI: 10.1136/Bmjopen-2016-013187  0.343
2017 Gabel S, Mak E, Cervenka S, Jones PS, Surendranathan A, Bevan-Jones WR, Passamonti L, Rodriguez PV, Su L, Williams GB, Arnold R, Firbank MJ, Rowe JB, O'Brien JT. [18F]AV-1451 PET IMAGING OF TAU PATHOLOGY PREDICTS WHITE MATTER HYPERINTENSITIES IN HEALTHY AGING, MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE: THE NIMROD STUDY Alzheimer's & Dementia. 13: P1236-P1237. DOI: 10.1016/J.Jalz.2017.07.439  0.359
2017 Mirza SS, Mutsaerts HJMM, Cash DM, Bocchetta M, Thomas DL, Dick KM, Swieten JCv, Borroni B, Galimberti D, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R, et al. Fronto-Subcortical Hypoperfusion In Presymptomatic Ftd Is Associated With Behavioral Measures, But Not Cognitive Deficits: The Genfi Study Alzheimers & Dementia. 13: 551. DOI: 10.1016/J.Jalz.2017.07.148  0.302
2017 Koychev IG, Gunn RN, Firouzian A, Lawson J, Zamboni G, Ridha BH, Sahakian B, Rowe JB, Thomas A, Rochester L, Ffytche D, Howard RJ, Zetterberg H, MacKay C, Lovestone S. [P1-448]: PET TAU AND AMYLOID-BETA DIFFER IN THEIR RELATIONSHIP TO AGE, COGNITION AND CSF BIOMARKERS IN MILD ALZHEIMER's DISEASE: AN OBSERVATIONAL STUDY Alzheimer's & Dementia. 13: P456-P457. DOI: 10.1016/J.Jalz.2017.06.464  0.337
2017 Surendranathan A, Su L, Passamonti L, Hong YT, Bevan-Jones WR, Arnold R, Rodriguez PV, Mak E, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT. [P1-462]: [11C]Pk11195 Pet Imaging Reveals Neuroinflammation In Dementia With Lewy Bodies Is Negatively Associated With Disease Severity: Nimrod Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2351  0.317
2017 Minett T, Su L, Mak E, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT. Longitudinal Diffusion Tensor Imaging As A Predictor Of Cognitive Domains Decline In Early Stage Parkinson’S Disease: Icicle-Pd Study Alzheimers & Dementia. 13: 1353. DOI: 10.1016/J.Jalz.2017.06.2088  0.308
2017 Cope TE, Borchert R, Rittman T, Jones S, Passamonti L, Rodriguez PV, Bevan-Jones WR, O'Brien JT, Rowe JB. [P2-375]: THE EFFECT OF TAU BURDEN ON FUNCTIONAL CONNECTIVITY IN ALZHEIMER'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY Alzheimer's & Dementia. 13: P770-P771. DOI: 10.1016/J.Jalz.2017.06.1030  0.338
2017 Mak E, Gabel S, Cervenka S, Su L, Surendranathan A, Bevan-Jones WR, Hong YT, Arnold R, Rodriguez PV, Jones S, Williams GB, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT. IN VIVO MAPPING OF TAU DEPOSITION, PERFUSION, AND CORTICAL THINNING IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P140-P141. DOI: 10.1016/J.Jalz.2017.06.1013  0.349
2017 Koychev IG, Gunn RN, Firouzian A, Lawson J, Zamboni G, Ridha BH, Sahakian B, Rowe JB, Thomas A, Rochester L, Ffytche D, Howard RJ, Zetterberg H, MacKay C, Lovestone S. PET TAU AND AMYLOID-BETA DIFFER IN THEIR RELATIONSHIP TO AGE, COGNITION AND CSF BIOMARKERS IN MILD ALZHEIMER’S DISEASE: AN OBSERVATIONAL STUDY Alzheimer's & Dementia. 13: P243. DOI: 10.1016/J.Jalz.2017.06.094  0.323
2017 Skandali N, Rowe J, Deakin J, Robbins T, Sahakian B. Serotonergic modulation of cognition; An acute challenge European Psychiatry. 41: S350-S350. DOI: 10.1016/J.Eurpsy.2017.02.326  0.305
2016 Bevan Jones WR, Cope TE, Passamonti L, Fryer TD, Hong YT, Aigbirhio F, Kril JJ, Forrest SL, Allinson K, Coles JP, Simon Jones P, Spillantini MG, Hodges JR, O'Brien JT, Rowe JB. [(18)F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation. Annals of Clinical and Translational Neurology. 3: 940-947. PMID 28097206 DOI: 10.1002/Acn3.366  0.327
2016 Rittman T, Coyle-Gilchrist IT, Rowe JB. Managing cognition in progressive supranuclear palsy. Neurodegenerative Disease Management. PMID 27879155 DOI: 10.2217/Nmt-2016-0027  0.32
2016 Rittman T, Rubinov M, Vértes PE, Patel AX, Ginestet CE, Ghosh BC, Barker RA, Spillantini MG, Bullmore ET, Rowe JB. Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy. Neurobiology of Aging. 48: 153-160. PMID 27697694 DOI: 10.1016/J.Neurobiolaging.2016.09.001  0.382
2016 Wolpe N, Ingram JN, Tsvetanov KA, Geerligs L, Kievit RA, Henson RN, Wolpert DM, Rowe JB. Ageing increases reliance on sensorimotor prediction through structural and functional differences in frontostriatal circuits. Nature Communications. 7: 13034. PMID 27694879 DOI: 10.1038/Ncomms13034  0.311
2016 Udow SJ, Robertson AD, MacIntosh BJ, Espay AJ, Rowe JB, Lang AE, Masellis M. 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27613160 DOI: 10.1136/Jnnp-2016-314123  0.333
2016 Savulich G, Piercy T, Bruhl AB, Fox C, Suckling J, Rowe JB, O'Brien JT, Sahakian BJ. Focusing the neuroscience and societal implications of cognitive enhancers. Clinical Pharmacology and Therapeutics. PMID 27557349 DOI: 10.1002/Cpt.457  0.306
2016 Phillips HN, Blenkmann A, Hughes LE, Kochen S, Bekinschtein TA, Cam-Can, Rowe JB. Convergent evidence for hierarchical prediction networks from human electrocorticography and magnetoencephalography. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 82: 192-205. PMID 27389803 DOI: 10.1016/J.Cortex.2016.05.001  0.322
2016 Rae CL, Nombela C, Rodríguez PV, Ye Z, Hughes LE, Jones PS, Ham T, Rittman T, Coyle-Gilchrist I, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Atomoxetine restores the response inhibition network in Parkinson's disease. Brain : a Journal of Neurology. PMID 27343257 DOI: 10.1093/Brain/Aww138  0.395
2016 Zhang J, Nombela C, Wolpe N, Barker RA, Rowe JB. Time on timing: Dissociating premature responding from interval sensitivity in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27091513 DOI: 10.1002/Mds.26631  0.326
2016 Tsvetanov KA, Henson RN, Tyler LK, Razi A, Geerligs L, Ham TE, Rowe JB. Extrinsic and Intrinsic Brain Network Connectivity Maintains Cognition across the Lifespan Despite Accelerated Decay of Regional Brain Activation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 3115-26. PMID 26985024 DOI: 10.1523/Jneurosci.2733-15.2016  0.319
2016 Borchert RJ, Rittman T, Passamonti L, Ye Z, Sami S, Jones SP, Nombela C, Rodríguez PV, Vatansever D, Rae CL, Hughes LE, Robbins TW, Rowe JB. Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26837463 DOI: 10.1038/Npp.2016.18  0.385
2016 Ye Z, Rae CL, Nombela C, Ham T, Rittman T, Jones PS, Rodríguez PV, Coyle-Gilchrist I, Regenthal R, Altena E, Housden CR, Maxwell H, Sahakian BJ, Barker RA, Robbins TW, ... Rowe JB, et al. Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures. Human Brain Mapping. PMID 26757216 DOI: 10.1002/Hbm.23087  0.359
2016 Bevan-Jones WR, Aigbirhio F, Passamonti L, Fryer T, Hong Y, Coles J, O'Brien J, Rowe J. IMAGING IN DEMENTIA Journal of Neurology, Neurosurgery & Psychiatry. 87: e1.166-e1. DOI: 10.1136/Jnnp-2016-315106.32  0.352
2016 Cope T, Sohoglu E, Patterson K, Dawson C, Grube M, Sedley W, Davis M, Rowe J. MEG REVEALS SPEECH PROCESSING DELAY IN PROGRESSIVE NON FLUENT APHASIA Journal of Neurology, Neurosurgery & Psychiatry. 87: e1.74-e1. DOI: 10.1136/Jnnp-2016-315106.165  0.344
2016 Mutsaerts HJMM, Rohrer JD, Thomas DL, Cash DM, Vita Ed, Nicholas JM, Swieten JCv, Dopper EGP, Jiskoot LC, Minkelen Rv, Rombouts SARB, Dick KM, Bocchetta M, Cardoso MJ, Espak M, ... ... Rowe J, et al. Cerebral Perfusion As An Imaging Biomarker Of Presymptomatic Genetic Frontotemporal Dementia: Preliminary Results From The Genetic Frontotemporal Dementia Initiative (Genfi) Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.772  0.364
2016 Gabel S, Mak E, Su L, Williams GB, Arnold R, Passamonti L, Rodríguezi P, Surendranathan A, Bevan-Jones WR, Rowe J, O'Brien JT. A Comparison Of Neuropsychiatric Symptoms And Cognitive Profiles Between Dementia With Lewy Bodies And Progressive Supranuclear Palsy: The Nimrod Study Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1975  0.326
2016 Mak E, Gabel S, Su L, Williams GB, Arnold R, Passamonti L, Rodríguezi P, Surendranathan A, Bevan-Jones WR, Rowe J, O'Brien JT. Hippocampal Ca1 Involvement In Dementia With Lewy Bodies, Alzheimer'S Disease And Mild Cognitive Impairment: The Nimrod Study Alzheimers & Dementia. 12: 708. DOI: 10.1016/J.Jalz.2016.06.1394  0.344
2015 Suckling J, Simas T, Chattopadhyay S, Tait R, Su L, Williams G, Rowe JB, O'Brien JT. A Winding Road: Alzheimer's Disease Increases Circuitous Functional Connectivity Pathways. Frontiers in Computational Neuroscience. 9: 140. PMID 26635593 DOI: 10.3389/Fncom.2015.00140  0.366
2015 Zhang J, Rittman T, Nombela C, Fois A, Coyle-Gilchrist I, Barker RA, Hughes LE, Rowe JB. Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease. Brain : a Journal of Neurology. PMID 26582559 DOI: 10.1093/Brain/Awv331  0.352
2015 Wolpe N, Nombela C, Rowe JB. Dopaminergic modulation of positive expectations for goal-directed action: evidence from Parkinson's disease. Frontiers in Psychology. 6: 1514. PMID 26500582 DOI: 10.3389/Fpsyg.2015.01514  0.324
2015 Surendranathan A, Rowe JB, O'Brien JT. Neuroinflammation in Lewy body dementia. Parkinsonism & Related Disorders. PMID 26493111 DOI: 10.1016/J.Parkreldis.2015.10.009  0.382
2015 Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain : a Journal of Neurology. PMID 26173861 DOI: 10.1093/Brain/Awv211  0.406
2015 Phillips HN, Blenkmann A, Hughes LE, Bekinschtein TA, Rowe JB. Hierarchical Organization of Frontotemporal Networks for the Prediction of Stimuli across Multiple Dimensions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 9255-64. PMID 26109651 DOI: 10.1523/Jneurosci.5095-14.2015  0.335
2015 Hughes LE, Rittman T, Regenthal R, Robbins TW, Rowe JB. Improving response inhibition systems in frontotemporal dementia with citalopram Brain. 138: 1961-1975. PMID 26001387 DOI: 10.1093/Brain/Awv133  0.383
2015 Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Løkkegaard A, Siebner HR. Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans. Brain : a Journal of Neurology. 138: 1658-66. PMID 25882651 DOI: 10.1093/Brain/Awv096  0.353
2015 Mason SL, Zhang J, Begeti F, Guzman NV, Lazar AS, Rowe JB, Barker RA, Hampshire A. The role of the amygdala during emotional processing in Huntington's disease: from pre-manifest to late stage disease. Neuropsychologia. 70: 80-9. PMID 25700742 DOI: 10.1016/J.Neuropsychologia.2015.02.017  0.365
2015 Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, De Vita E, Masellis M, ... ... Rowe JB, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. The Lancet. Neurology. 14: 253-62. PMID 25662776 DOI: 10.1016/S1474-4422(14)70324-2  0.36
2015 Rae CL, Hughes LE, Anderson MC, Rowe JB. The prefrontal cortex achieves inhibitory control by facilitating subcortical motor pathway connectivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 786-94. PMID 25589771 DOI: 10.1523/Jneurosci.3093-13.2015  0.328
2015 Winder-Rhodes SE, Hampshire A, Rowe JB, Peelle JE, Robbins TW, Owen AM, Barker RA. Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals. Neurobiology of Aging. 36: 1519-28. PMID 25577413 DOI: 10.1016/J.Neurobiolaging.2014.12.006  0.322
2015 Zhang J, Rowe JB. The neural signature of information regularity in temporally extended event sequences. Neuroimage. 107: 266-76. PMID 25524648 DOI: 10.1016/J.Neuroimage.2014.12.021  0.315
2015 Napier TC, Corvol JC, Grace AA, Roitman JD, Rowe J, Voon V, Strafella AP. Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 141-9. PMID 25476402 DOI: 10.1002/Mds.26068  0.332
2015 Hsieh S, McGrory S, Leslie F, Dawson K, Ahmed S, Butler CR, Rowe JB, Mioshi E, Hodges JR. The Mini-Addenbrooke's Cognitive Examination: a new assessment tool for dementia. Dementia and Geriatric Cognitive Disorders. 39: 1-11. PMID 25227877 DOI: 10.1159/000366040  0.325
2015 Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Improving response inhibition in Parkinson's disease with atomoxetine. Biological Psychiatry. 77: 740-8. PMID 24655598 DOI: 10.1016/J.Biopsych.2014.01.024  0.318
2015 Cash DM, Dick KM, Fellows A, Espak M, Swieten JCv, Galimberti D, Borroni B, Masellis M, Tagliavini F, Graff C, Rowe J, Frisoni GB, Laforce R, Finger E, Sorbi S, et al. MONDAY, JULY 20, 2015 ORAL SESSIONS O2-01 NEUROIMAGING: IMAGING — AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE AND FTLDGrey matter differences in genetic frontotemporal dementia: Results from the genfi study Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.130  0.342
2015 Cash DM, Dick KM, Fellows A, Espak M, Swieten JCv, Galimberti D, Borroni B, Masellis M, Tagliavini F, Graff C, Rowe J, Frisoni GB, Laforce R, Finger E, Sorbi S, et al. Grey matter differences in genetic frontotemporal dementia: Results from the genfi study Alzheimers & Dementia. 11: 171. DOI: 10.1016/J.Jalz.2015.06.075  0.305
2014 Shafto MA, Tyler LK, Dixon M, Taylor JR, Rowe JB, Cusack R, Calder AJ, Marslen-Wilson WD, Duncan J, Dalgleish T, Henson RN, Brayne C, Matthews FE. The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing. Bmc Neurology. 14: 204. PMID 25412575 DOI: 10.1186/S12883-014-0204-1  0.315
2014 Slattery CF, Beck JA, Harper L, Adamson G, Abdi Z, Uphill J, Campbell T, Druyeh R, Mahoney CJ, Rohrer JD, Kenny J, Lowe J, Leung KK, Barnes J, Clegg SL, ... ... Rowe JB, et al. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 602-608.e4. PMID 25160042 DOI: 10.1016/J.Jalz.2014.05.1751  0.325
2014 Nombela C, Rowe JB, Winder-Rhodes SE, Hampshire A, Owen AM, Breen DP, Duncan GW, Khoo TK, Yarnall AJ, Firbank MJ, Chinnery PF, Robbins TW, O'Brien JT, Brooks DJ, Burn DJ, et al. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain : a Journal of Neurology. 137: 2743-58. PMID 25080285 DOI: 10.1093/Brain/Awu201  0.422
2014 Yao N, Shek-Kwan Chang R, Cheung C, Pang S, Lau KK, Suckling J, Rowe JB, Yu K, Ka-Fung Mak H, Chua SE, Ho SL, McAlonan GM. The default mode network is disrupted in Parkinson's disease with visual hallucinations. Human Brain Mapping. 35: 5658-66. PMID 24985056 DOI: 10.1002/Hbm.22577  0.33
2014 Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, ... ... Rowe JB, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. The Lancet. Neurology. 13: 686-99. PMID 24943344 DOI: 10.1016/S1474-4422(14)70065-1  0.302
2014 Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Løkkegaard A, Siebner HR. The acute brain response to levodopa heralds dyskinesias in Parkinson disease. Annals of Neurology. 75: 829-36. PMID 24889498 DOI: 10.1002/Ana.24138  0.307
2014 Burrell JR, Hodges JR, Rowe JB. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 684-93. PMID 24757116 DOI: 10.1002/Mds.25872  0.363
2014 Yu R, Mobbs D, Seymour B, Rowe JB, Calder AJ. The neural signature of escalating frustration in humans. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 54: 165-78. PMID 24699035 DOI: 10.1016/J.Cortex.2014.02.013  0.307
2014 Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease. Brain : a Journal of Neurology. 137: 1145-55. PMID 24578545 DOI: 10.1093/Brain/Awu032  0.4
2014 Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB. Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 925-9. PMID 24521567 DOI: 10.1136/Jnnp-2013-307035  0.317
2014 Nombela C, Rittman T, Robbins TW, Rowe JB. Multiple modes of impulsivity in Parkinson's disease. Plos One. 9: e85747. PMID 24465678 DOI: 10.1371/Journal.Pone.0085747  0.36
2014 Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology. 82: 308-16. PMID 24363137 DOI: 10.1212/Wnl.0000000000000066  0.314
2014 Wolpe N, Moore JW, Rae CL, Rittman T, Altena E, Haggard P, Rowe JB. The medial frontal-prefrontal network for altered awareness and control of action in corticobasal syndrome. Brain : a Journal of Neurology. 137: 208-20. PMID 24293266 DOI: 10.1093/Brain/Awt302  0.35
2014 von dem Hagen EA, Stoyanova RS, Rowe JB, Baron-Cohen S, Calder AJ. Direct gaze elicits atypical activation of the theory-of-mind network in autism spectrum conditions. Cerebral Cortex (New York, N.Y. : 1991). 24: 1485-92. PMID 23324559 DOI: 10.1093/Cercor/Bht003  0.314
2014 Mason S, Zhang J, Rowe J, Barker R, Hampshire A. E24 Frontostriatal Abnormalities In Huntington's Disease: An Fmri Study Journal of Neurology, Neurosurgery & Psychiatry. 85: A45-A45. DOI: 10.1136/Jnnp-2014-309032.127  0.371
2013 Ghosh BC, Carpenter RH, Rowe JB. A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy. Plos One. 8: e74486. PMID 24058574 DOI: 10.1371/Journal.Pone.0074486  0.361
2013 Mehta AR, Rowe JB, Schrag AE. Imaging psychogenic movement disorders. Current Neurology and Neuroscience Reports. 13: 402. PMID 24057974 DOI: 10.1007/S11910-013-0402-Z  0.341
2013 Zhang J, Kriegeskorte N, Carlin JD, Rowe JB. Choosing the rules: distinct and overlapping frontoparietal representations of task rules for perceptual decisions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11852-62. PMID 23864675 DOI: 10.1523/Jneurosci.5193-12.2013  0.302
2013 Hughes LE, Ghosh BC, Rowe JB. Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy. Neuroimage. Clinical. 2: 459-468. PMID 23853762 DOI: 10.1016/J.Nicl.2013.03.009  0.366
2013 Hughes LE, Rowe JB. The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia. Journal of Cognitive Neuroscience. 25: 802-13. PMID 23469882 DOI: 10.1162/Jocn_A_00356  0.37
2013 Schrag AE, Mehta AR, Bhatia KP, Brown RJ, Frackowiak RS, Trimble MR, Ward NS, Rowe JB. The functional neuroimaging correlates of psychogenic versus organic dystonia. Brain : a Journal of Neurology. 136: 770-81. PMID 23436503 DOI: 10.1093/Brain/Awt008  0.331
2013 Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. American Journal of Human Genetics. 92: 345-53. PMID 23434116 DOI: 10.1016/J.Ajhg.2013.01.011  0.33
2013 Macoveanu J, Hornboll B, Elliott R, Erritzoe D, Paulson OB, Siebner H, Knudsen GM, Rowe JB. Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 996-1005. PMID 23303045 DOI: 10.1038/Npp.2012.264  0.31
2013 Passingham RE, Rowe JB, Sakai K. Has brain imaging discovered anything new about how the brain works? Neuroimage. 66: 142-50. PMID 23123632 DOI: 10.1016/J.Neuroimage.2012.10.079  0.318
2013 Müller U, Rowe JB, Rittman T, Lewis C, Robbins TW, Sahakian BJ. Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology. 64: 490-5. PMID 22820554 DOI: 10.1016/J.Neuropharm.2012.07.009  0.317
2013 Hughes LE, Altena E, Barker RA, Rowe JB. Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions. Cerebral Cortex (New York, N.Y. : 1991). 23: 1572-81. PMID 22661404 DOI: 10.1093/Cercor/Bhs144  0.358
2013 Ye Z, Altena E, Nombela-Otero C, Housden C, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Citalopram enhances action inhibition systems in Parkinson's disease F1000research. 4. DOI: 10.7490/F1000Research.1093613.1  0.353
2013 Chaal S, Rowe J. DOPAMINE TRANSPORTER (DAT) IMAGING CAN BE NORMAL WITH NEUROPATHOLOGICALLY CONFIRMED CORTIOBASAL DEGENERATION Journal of Neurology, Neurosurgery & Psychiatry. 84: e2.59-e2. DOI: 10.1136/Jnnp-2013-306573.151  0.385
2013 Rittman T, Ghosh B, Rowe J. Exploration of functional brain networks in neurodegenerative disease The Lancet. 381. DOI: 10.1016/S0140-6736(13)60532-2  0.353
2012 Coyle-Gilchrist IT, Peck LF, Rowe JB. Research paper does not show causal link between benzodiazepine use and diagnosis of dementia. Bmj (Clinical Research Ed.). 345: e7984; author reply . PMID 23183061 DOI: 10.1136/Bmj.E7984  0.309
2012 Zhang J, Hughes LE, Rowe JB. Selection and inhibition mechanisms for human voluntary action decisions. Neuroimage. 63: 392-402. PMID 22776456 DOI: 10.1016/J.Neuroimage.2012.06.058  0.304
2012 Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB. White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage. 62: 1675-84. PMID 22713671 DOI: 10.1016/J.Neuroimage.2012.06.012  0.329
2012 Goulden N, McKie S, Thomas EJ, Downey D, Juhasz G, Williams SR, Rowe JB, Deakin JF, Anderson IM, Elliott R. Reversed frontotemporal connectivity during emotional face processing in remitted depression. Biological Psychiatry. 72: 604-11. PMID 22682158 DOI: 10.1016/J.Biopsych.2012.04.031  0.3
2012 Ghosh BC, Calder AJ, Peers PV, Lawrence AD, Acosta-Cabronero J, Pereira JM, Hodges JR, Rowe JB. Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain : a Journal of Neurology. 135: 2089-102. PMID 22637582 DOI: 10.1093/Brain/Aws128  0.341
2012 Rowe JB, Siebner HR. The motor system and its disorders. Neuroimage. 61: 464-77. PMID 22227135 DOI: 10.1016/J.Neuroimage.2011.12.042  0.324
2012 Rittman T, Ghosh B, Shirer WR, Greicius MD, Rowe JB. Beyond the default mode: resting state cognitive and motor networks in PSP and CBD dementias F1000research. 3. DOI: 10.7490/F1000Research.1090493.1  0.314
2012 McColgan P, Evans J, Breen DP, Mason SL, Ghosh B, Rittman T, Rowe J, Nestor P, Barker RA, Williams-Gray CH. 1154 The utility of the Addenbrooke's Cognitive Examination-Revised (ACE-R) in Parkinson's disease Journal of Neurology, Neurosurgery & Psychiatry. 83: e1.147-e1. DOI: 10.1136/Jnnp-2011-301993.3  0.319
2012 Ghosh B, Hodges JR, Rowe JB. 112 Is cognition stable in progressive supranuclear palsy after diagnosis, or are we testing the wrong thing? Journal of Neurology, Neurosurgery & Psychiatry. 83: e1.62-e1. DOI: 10.1136/Jnnp-2011-301993.154  0.345
2011 Hughes LE, Nestor PJ, Hodges JR, Rowe JB. Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions. Brain : a Journal of Neurology. 134: 2513-22. PMID 21840892 DOI: 10.1093/Brain/Awr196  0.387
2011 Horwitz B, Rowe JB. Functional biomarkers for neurodegenerative disorders based on the network paradigm. Progress in Neurobiology. 95: 505-9. PMID 21801801 DOI: 10.1016/J.Pneurobio.2011.07.005  0.306
2011 Breen DP, Rowe JB, Barker RA. Role of brain imaging in early parkinsonism. Bmj (Clinical Research Ed.). 342: d638. PMID 21345904 DOI: 10.1136/Bmj.D638  0.306
2011 Perneczky R, Ghosh BC, Hughes L, Carpenter RH, Barker RA, Rowe JB. Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity. Neurobiology of Disease. 43: 79-85. PMID 21310235 DOI: 10.1016/J.Nbd.2011.01.032  0.366
2011 Ghosh BCP, Acosta-Cabronero J, Hodges JR, Rowe JB. 08 Neural correlates of cognition in progressive supranuclear palsy Journal of Neurology, Neurosurgery & Psychiatry. 82: e1-e1. DOI: 10.1136/Jnnp.2010.235572.8  0.381
2010 Mobbs D, Yu R, Rowe JB, Eich H, FeldmanHall O, Dalgleish T. Neural activity associated with monitoring the oscillating threat value of a tarantula. Proceedings of the National Academy of Sciences of the United States of America. 107: 20582-6. PMID 21059963 DOI: 10.1073/Pnas.1009076107  0.311
2010 Rowe JB. Connectivity Analysis is Essential to Understand Neurological Disorders. Frontiers in Systems Neuroscience. 4. PMID 20948582 DOI: 10.3389/Fnsys.2010.00144  0.355
2010 Rowe JB, Hughes L, Nimmo-Smith I. Action selection: a race model for selected and non-selected actions distinguishes the contribution of premotor and prefrontal areas. Neuroimage. 51: 888-96. PMID 20188184 DOI: 10.1016/J.Neuroimage.2010.02.045  0.307
2010 Hughes LE, Barker RA, Owen AM, Rowe JB. Parkinson's disease and healthy aging: independent and interacting effects on action selection. Human Brain Mapping. 31: 1886-99. PMID 20162604 DOI: 10.1002/Hbm.20979  0.349
2010 Rowe JB, Hughes LE, Barker RA, Owen AM. Dynamic causal modelling of effective connectivity from fMRI: are results reproducible and sensitive to Parkinson's disease and its treatment? Neuroimage. 52: 1015-26. PMID 20056151 DOI: 10.1016/J.Neuroimage.2009.12.080  0.365
2010 Rowe JB, Hughes L, Williams-Gray CH, Bishop S, Fallon S, Barker RA, Owen AM. The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease. Neurobiology of Aging. 31: 1064-8. PMID 18755526 DOI: 10.1016/J.Neurobiolaging.2008.07.009  0.333
2010 Ghosh B, Rowe JB, Carpenter RHS, Calder AJ, Peers PV, Lawrence AD, Hodges JR. PAW20 Saccadic correlates of cognition in progressive supranuclear palsy Journal of Neurology, Neurosurgery & Psychiatry. 81: e29-e29. DOI: 10.1136/Jnnp.2010.226340.49  0.339
2010 Perneczky R, Gosh BC, Hughes L, Carpenter RH, Barker RA, Rowe JB. IC-P-023: Associations between regional brain atrophy, executive control, and saccadic latency in Parkinson's disease and healthy aging Alzheimer's & Dementia. 6: S14-S14. DOI: 10.1016/J.Jalz.2010.05.038  0.315
2009 Sharma N, Baron JC, Rowe JB. Motor imagery after stroke: relating outcome to motor network connectivity. Annals of Neurology. 66: 604-16. PMID 19938103 DOI: 10.1002/Ana.21810  0.305
2009 Grahn JA, Rowe JB. Feeling the beat: premotor and striatal interactions in musicians and nonmusicians during beat perception. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 7540-8. PMID 19515922 DOI: 10.1523/Jneurosci.2018-08.2009  0.307
2009 Rowe J, Hughes L, Barker R. Action Selection: the different effects of aging and Parkinson's disease Neuroimage. 47. DOI: 10.1016/S1053-8119(09)71056-0  0.302
2008 Passamonti L, Rowe JB, Ewbank M, Hampshire A, Keane J, Calder AJ. Connectivity from the ventral anterior cingulate to the amygdala is modulated by appetitive motivation in response to facial signals of aggression. Neuroimage. 43: 562-70. PMID 18722533 DOI: 10.1016/J.Neuroimage.2008.07.045  0.301
2008 Rowe JB, Hughes L, Ghosh BC, Eckstein D, Williams-Gray CH, Fallon S, Barker RA, Owen AM. Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition. Brain : a Journal of Neurology. 131: 2094-105. PMID 18577547 DOI: 10.1093/Brain/Awn112  0.378
2008 Rowe JB, Eckstein D, Braver T, Owen AM. How does reward expectation influence cognition in the human brain? Journal of Cognitive Neuroscience. 20: 1980-92. PMID 18416677 DOI: 10.1162/Jocn.2008.20140  0.341
2008 Rowe J, Hughes L, Eckstein D, Owen AM. Rule-selection and action-selection have a shared neuroanatomical basis in the human prefrontal and parietal cortex. Cerebral Cortex (New York, N.Y. : 1991). 18: 2275-85. PMID 18234684 DOI: 10.1093/Cercor/Bhm249  0.313
2007 Rowe JB, Sakai K, Lund TE, Ramsøy T, Christensen MS, Baare WF, Paulson OB, Passingham RE. Is the prefrontal cortex necessary for establishing cognitive sets? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 13303-10. PMID 18045924 DOI: 10.1523/Jneurosci.2349-07.2007  0.329
2006 Rowe JB, Siebner H, Filipovic SR, Cordivari C, Gerschlager W, Rothwell J, Frackowiak R. Aging is associated with contrasting changes in local and distant cortical connectivity in the human motor system. Neuroimage. 32: 747-60. PMID 16797190 DOI: 10.1016/J.Neuroimage.2006.03.061  0.334
2006 Christensen MS, Ramsøy TZ, Lund TE, Madsen KH, Rowe JB. An fMRI study of the neural correlates of graded visual perception. Neuroimage. 31: 1711-25. PMID 16626975 DOI: 10.1016/J.Neuroimage.2006.02.023  0.303
2005 Vitali P, Abutalebi J, Tettamanti M, Rowe J, Scifo P, Fazio F, Cappa SF, Perani D. Generating animal and tool names: an fMRI study of effective connectivity. Brain and Language. 93: 32-45. PMID 15766766 DOI: 10.1016/J.Bandl.2004.08.005  0.319
2005 Rowe JB, Stephan KE, Friston K, Frackowiak RS, Passingham RE. The prefrontal cortex shows context-specific changes in effective connectivity to motor or visual cortex during the selection of action or colour. Cerebral Cortex (New York, N.Y. : 1991). 15: 85-95. PMID 15238443 DOI: 10.1093/Cercor/Bhh111  0.307
2003 Siebner HR, Filipovic SR, Rowe JB, Cordivari C, Gerschlager W, Rothwell JC, Frackowiak RS, Bhatia KP. Patients with focal arm dystonia have increased sensitivity to slow-frequency repetitive TMS of the dorsal premotor cortex. Brain : a Journal of Neurology. 126: 2710-25. PMID 12937071 DOI: 10.1093/Brain/Awg282  0.319
2003 Stephan KE, Marshall JC, Friston KJ, Rowe JB, Ritzl A, Zilles K, Fink GR. Lateralized cognitive processes and lateralized task control in the human brain. Science (New York, N.Y.). 301: 384-6. PMID 12869765 DOI: 10.1126/Science.1086025  0.33
2002 Rowe J, Friston K, Frackowiak R, Passingham R. Attention to action: specific modulation of corticocortical interactions in humans. Neuroimage. 17: 988-98. PMID 12377172 DOI: 10.1006/Nimg.2002.1156  0.318
2002 Rowe J, Stephan KE, Friston K, Frackowiak R, Lees A, Passingham R. Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions. Brain : a Journal of Neurology. 125: 276-89. PMID 11844728 DOI: 10.1093/Brain/Awf036  0.352
2001 Rowe JB, Stephan K, Frackowiak R, Lees A, Passingham R. Attention to action in parkinson's disease Neuroimage. 13: 830. DOI: 10.1016/S1053-8119(01)92172-X  0.303
1999 Rowe JB, Frackowiak RS. The impact of brain imaging technology on our understanding of motor function and dysfunction. Current Opinion in Neurobiology. 9: 728-34. PMID 10607634 DOI: 10.1016/S0959-4388(99)00025-2  0.302
Show low-probability matches.